Skip to content

Research on the combined effect of systemic nutrition and rhythmic exercise on people with abnormal metabolism of motor system

Research on the combined effect of systemic nutrition and rhythmic exercise on people with abnormal metabolism of motor system

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052416
Enrollment
Unknown
Registered
2021-10-25
Start date
2021-10-31
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis and osteoporosis

Interventions

intervention group:the combined effect of systemic nutrition and rhythmic exercise
The control group:There is no nutritional intervention and exercise is not mandatory

Sponsors

Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. The experimental volunteers of this subject have related manifestations of osteoporosis or knee osteoarthritis risk. Through the special "Osteoporosis Risk Self-Assessment Scale" (and the "Osteoarthritis Self-Subjective Symptom Assessment Scale", the people who meet the test are screened, and at the same time meet the "Osteoporosis Risk Self-Assessment Scale" and "Osteoarthritis Self-Assessment Scale" The conditions of the self-inflammation self-subjective symptom evaluation scale, which meet the requirements of the project; 2. Gender is not limited; 3. Aged 30 to 70 years; 4. Able to exercise independently and safely (walking 3 kilometers independently), good compliance, and follow the fitness of exercise.

Exclusion criteria

Exclusion criteria: 1. Those who had taken drugs for osteoarthritis or osteoporosis in the past one month affected the judgment of the results; 2. Pregnant or lactating women; 3. Patients with serious complications, complicated with serious diseases of heart, brain, liver, kidney and hematopoietic system, psychiatric patients, unable to take care of themselves; 4. Patients with asthma, alcoholism, hyperthyroidism, malignant tumor and hormone therapy; 5. Unable to eat test samples according to regulations, or incomplete data, affecting the judgment of efficacy; 6. Patients participating in other clinical trials; 7. Other reasons are not considered suitable for clinical subjects.

Design outcomes

Primary

MeasureTime frame
BMD T value;

Countries

China

Contacts

Public ContactJiang Tong

Capital Medical University

jiangtong@df2000.cn+86 18601015660

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026